Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis?

Pediatric Allergy and Immunology

Volumn 17, Issue 4, 2006, Pages 259-268

  Keskin, Ozlem ^a   Alyamac, Evrim ^a   Tuncer, Ayfer ^a   Dogan, Cahit ^a   Adalioglu, Gonul ^a   Sekerel, Bulent Enis ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Allergic rhinitis; Children; Leukotriene; Loratadine; Montelukast; Nasal challenge

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; MONTELUKAST; PLACEBO; POLLEN ANTIGEN;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; FEMALE; GRASS POLLEN; HUMAN; MALE; NOSE AIRFLOW; NOSE CONGESTION; NOSE OBSTRUCTION; POLLEN ALLERGY; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEASONAL VARIATION; SINGLE DRUG DOSE; SNEEZING; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACETATES; ANTI-ALLERGIC AGENTS; ANTI-ASTHMATIC AGENTS; AREA UNDER CURVE; CHILD; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; LORATADINE; MALE; POACEAE; QUINOLINES; RESPIRATORY FUNCTION TESTS; RHINITIS, ALLERGIC, SEASONAL; RHINOMANOMETRY; TIME FACTORS; TREATMENT OUTCOME;

EID: 33745041258     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2006.00397.x     Document Type: Article

References (35)

1. Warner JO. The role of leukotriene receptor antagonists in the treatment of chronic asthma in childhood. Allergy 2001 : 56 Suppl. 66 22 9.
2. Salvi SS Krishna MT Sampson AP Holgate ST. The anti-inflammatory effects of leukotriene-modifying drugs and their use in asthma. Chest 2001 : 119 : 1533 46.
3. Naclerio RM. Allergic rhinitis. N Engl J Med 1991 : 325 : 860 9.
4. Howarth PH. Leukotrienes in rhinitis. Am J Respir Crit Care Med 2000 : 161 : S133 6.
5. Philip G Malmstrom K Hampel FC, et al., Montelukast Spring Rhinitis Study Group. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy 2002 : 32 : 1020 8.
6. Nayak AS Philip G Lu S Malice MP Reiss TF, et al., Montelukast Fall Rhinitis Investigator Group. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol 2002 : 88 : 592 600.
7. Wilson AM Orr LC Sims EJ Lipworth BJ. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clin Exp Allergy 2001 : 31 : 61 8.
8. van Adelsberg J Philip G Pedinoff AJ, et al., Montelukast Fall Rhinitis Study Group. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period. Allergy 2003 : 58 : 1268 76.
9. van Adelsberg J Philip G LaForce CF, et al., Montelukast Spring Rhinitis Investigator Group. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2003 : 90 : 214 22.
10. Meltzer EO Malmstrom K Lu S, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol 2000 : 105 : 917 22.
11. Wilson AM Sims EJ Orr LC, et al. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2001 : 87 : 344 9.
12. Klimek L Dormann D Jarman ER, et al. Short-term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions, but not peripheral T-cell responses, in patients with allergic rhinitis. Clin Exp Allergy 1999 : 29 : 1326 35.
13. Leynadier F Banoun L Dollois B, et al. Immunotherapy with a calcium phosphate-adsorbed five-grass-pollen extract in seasonal rhinoconjunctivitis: a double-blind, placebo-controlled study. Clin Exp Allergy 2001 : 31 : 988 96.
14. Howarth PH Salagean M Dokic D. Allergic rhinitis: not purely a histamine-related disease. Allergy 2000 : 55 Suppl. 64 7 16.
15. Creticos PS Peters SP Adkinson NF Jr., et al. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med 1984 : 310 : 1626 30.
16. Pipkorn U Proud D Lichtenstein LM, et al. Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest 1987 : 80 : 957 61.
17. Shaw RJ Fitzharris P Cromwell O Wardlaw AJ Kay AB. Allergen-induced release of sulphidopeptide leukotrienes (SRS-A) and LTB4 in allergic rhinitis. Allergy 1985 : 40 : 1 6.
18. Miadonna A Tedeschi A Leggieri E, et al. Behavior and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis. Am Rev Respir Dis 1987 : 136 : 357 62.
19. Freeland HS Pipkorn U Schleimer RP, et al. Leukotriene B4 as a mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol 1989 : 83 : 634 42.
20. Naclerio RM Proud D Togias AG, et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985 : 313 : 65 70.
21. Okuda M Watase T Mezawa A Liu CM. The role of leukotriene D4 in allergic rhinitis. Ann Allergy 1988 : 60 : 537 40.
22. Bisgaard H Olsson P Bende M. Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans. Clin Allergy 1986 : 16 : 289 97.
23. Flowers BK Proud D Kagey-Sobotka A Lichtenstein LM Naclerio RM. The effect of a leukotriene antagonist on the early response to antigen. Otolaryngol Head Neck Surg 1990 : 102 : 219 24.
24. Knapp HR. Reduced allergen-induced nasal obstruction and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. N Engl J Med 1990 : 323 : 1745 8.
25. Howarth PH Harrison K Lau L. The influence of 5-lipoxygenase inhibition in allergic rhinitis. Int Arch Allergy Immunol 1995 : 107 : 423 4.
26. Nathan RA. Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments. Ann Allergy Asthma Immunol 2003 : 90 : 182 90.
27. Wenzel SE Larsen GL Johnston K Voelkel NF Westcott JY. Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis 1990 : 142 : 112 9.
28. Pipkorn U Proud D Lichtenstein LM, et al. Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest 1987 : 80 : 957 61.
29. Knani J Campbell A Enander I, et al. Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis. J Allergy Clin Immunol 1992 : 90 : 880 9.
30. Dahlen SE Hedqvist P Hammarstrom S Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature 1980 : 288 : 484 6.
31. Adelroth E Morris MM Hargreave FE, et al. Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal controls. N Engl J Med 1986 : 315 : 480 84.
32. Laitinen LA Laitinen A Haahtela T, et al. Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet 1993 : 341 : 989 90.
33. Perry TT Corren J Philip G, et al. Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposure. Ann Allergy Asthma Immunol 2004 : 93 : 431 8.
34. Balzar S Wenzel SE Chu HW. Transbronchial biopsy as a tool to evaluate small airways in asthma. Eur Respir J 2002 : 20 : 254 9.
35. MacGlashan DW Jr. Schleimer RP Peters SP, et al. Generation of leukotrienes by purified human lung mast cells. J Clin Invest 1982 : 70 : 747 51.